Cerebrovascular Disease, Cognitive Impairment and Dementia.
John O'Brien, David Ames, Lars Gustafson, Marshal Folstein, and
Edmond Chiu (Eds.). 2004. London: Martin Dunitz, 406 pp., $79.95 (HB).
Cerebrovascular Disease, Cognitive Impairment and Dementia is
the second edition of Cerebrovascular Disease and Dementia
(2000). The new edition is over 160 pages longer than the earlier version,
with several new chapters devoted to the pathophysiology of
cerebrovascular disease [including provocative chapters on
neurotransmitter changes in vascular dementia (VaD), the contributions of
homocysteine and low vitamin B to VaD, and a good overview of hereditary
forms of VaD], vascular mild cognitive impairment, noncognitive
symptoms, and an expanded discussion of prevention and treatment. It is
written for both clinical and scientific audiences. As in the first
edition, there is a laudable comparative emphasis, with epidemiologic
studies of vascular dementia in Europe, North America, Japan, and China.
Indeed, the editors hail from the U.K, Australia, Sweden, and the U.S, and
this affords the volume a useful global perspective. With five editors and
22 additional contributors, however, this book suffers a bit from the
“too many cooks” syndrome. There is a good bit of redundancy.
After the fifth or sixth description of classification criteria for
vascular dementia, the reader begins to feel on the receiving end of some
repetitive rehearsal therapy for her own dementia.